MedTrace Logo

Interval Intraocular Pressure in Intravitreal Injection Study

NCT04868175 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2021-04-30

No results posted yet for this study

Summary

This is a prospective study of IOP in Intravitreal injections to evaluate:

1. IOP effect of intravitreal injection
2. IOP response to prophylactic beta blocker or Prostaglandin vs control (Hypromellose) over multiple time periods
3. IOP response in correlation to number of injections, IOL, type of anti VEGF, co morbidities

Conditions

Interventions

DRUG

Timolol

Topical eye drops for lowering intraocular pressure Beta blocker to reduce aqueous production

DRUG

Travatan

Topical eye drops for lowering intraocular pressure Prostaglandin analogue to increase aqueous outflow

DRUG

Hypromellose

Placebo eye drop, lubricant

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-03-01
Completion
2021-04-01

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04868175 on ClinicalTrials.gov